Table 1 Baseline characteristics of study participants
Total (n = 849) | Non-hospitalized Participants (n = 621) | Hospitalized Participants (n = 228) | |
|---|---|---|---|
Age (years), mean [SD] | 64.9 [10.7] | 64.3 [10.8] | 66.7 [10.1] |
Male, n (%) | 547 (64.4) | 397 (63.9) | 150 (65.8) |
Dialysis vintage (years), median [IQR] | 5.6 [2.2–11.6] | 5.5 [2.1–11.4] | 5.6 [2.3–12.6] |
BMI (kg/m2), n (%) | |||
< 18.5 | 176 (20.7) | 120 (19.3) | 56 (24.6) |
≥ 18.5 to < 25 | 559 (65.8) | 416 (67.0) | 143 (62.7) |
≥ 25 | 114 (13.4) | 85 (13.7) | 29 (12.7) |
Functional status score, n (%) | |||
< 8 | 49 (5.8) | 34 (5.5) | 15 (6.6) |
8 to < 11 | 77 (9.1) | 55 (8.9) | 22 (9.6) |
11 to < 13 | 171 (20.1) | 108 (17.4) | 63 (27.6) |
13 | 552 (65.0) | 424 (68.3) | 128 (56.1) |
Comorbidities, n (%) | |||
Diabetes | 308 (36.3) | 212 (34.1) | 96 (42.1) |
Cerebrovascular diseases | 71 (8.4) | 49 (7.9) | 22 (9.6) |
Coronary heart disease | 202 (23.8) | 138 (22.2) | 64 (28.1) |
Other cardiovascular diseases | 175 (20.6) | 118 (19.0) | 57 (25.0) |
Congestive heart disease | 131 (15.4) | 89 (14.3) | 42 (18.4) |
Cancer other than skin cancer | 84 (9.9) | 61 (9.8) | 23 (10.1) |
Neurological disease | 35 (4.1) | 25 (4.0) | 10 (4.4) |
Peripheral vascular disease | 110 (13.0) | 65 (10.5) | 45 (19.7) |
Dementia | 3 (0.4) | 2 (0.3) | 1 (0.4) |
Psychiatric disorder | 32 (3.8) | 21 (3.4) | 11 (4.8) |
Albumin (g/dL), mean [SD] | 3.7 [0.4] | 3.7 [0.4] | 3.6 [0.4] |
Phosphorus (mg/dL), mean [SD] | 5.3 [1.3] | 5.3 [1.3] | 5.3 [1.4] |
Creatinine (mg/dL), mean [SD] | 10.7 [2.5] | 10.9 [2.5] | 10.4 [2.5] |
Blood urea nitrogen (mg/dL), mean [SD] | 63.8 [14.1] | 64.1 [14.1] | 63.1 [14.1] |
Hemoglobin (g/L), mean [SD] | 10.6 [1.1] | 10.6 [1.1] | 10.5 [1.3] |
Single-pool Kt/V, mean [SD] | 1.4 [0.3] | 1.4 [0.3] | 1.4 [0.3] |